BridgeMD
New treatment option for Adhesive Capsulitis
Official title Additional Effects of Thoracic Spine Mobilization Combined With Glenohumeral Joint Mobilization on Pain, Range of Motion, and Functional Disability in Adhesive Capsulitis
ClinicalTrials.gov ID: NCT07328295
What this study is testing
- What it's testing
- Adhesive capsulitis is a debilitating shoulder condition characterized by pain, restricted range of motion (ROM), and significant functional limitations. Conventional treatment primarily targets the glenohumeral joint, often neglecting the role of regional interdependence, particularly the thoracic spine's influence on shoulder mobility.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 65
You may be able to join if
- Both male and female patients with a primary complaint of unilateral or bilateral shoulder pain
- Pain has persisted for at least 3 to 4 months
- Decreased shoulder ROM observed, including external shoulder rotation, abduction, internal rotation, and flexion
- Age range between 40 to 65 years
- Diagnosed with stage 2nd or 3rd of the disease.
You likely can't join if
- Patients if they had any shoulder pain resulting from systematic disease such as Rheumatoid Arthritis (morning stiffness \> 1 hour, multiple small...
- Recent shoulder joint fracture/ trauma.
- Thoracic Outlet Syndrome (Roos test).
- The presence of Cervical radiculopathy (Spurling's test)
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.